Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

OTHER 19 INDUSTRY 3 NIH 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 4 Squamous Cell Carcinoma of Head and Neck 3 Recurrent Squamous Cell Lung Carcinoma 3 Prostatic Neoplasms 2 Colorectal Neoplasms 2 Breast Neoplasms 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Non-small Cell Lung Cancer 1 Solid Malignancies 1 Small Cell Lung Carcinoma 1 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Lung Cancer Metastatic 1 Esophageal Neoplasms 1 Colorectal Cancer Metastatic 1 Cholangiocarcinoma 1 Carcinoma, Hepatocellular 1 Advanced Rare Tumours 1

Interventions

Gemcitabine 17 Fluorouracil 8 Capecitabine 6 Radiotherapy 5 Leucovorin 5 Albumin-Bound Paclitaxel 5 Taxes 4 Irinotecan 4 Cisplatin 4 130-nm albumin-bound paclitaxel 4 Specimen Handling 3 Radiotherapy, Conformal 3 Docetaxel 3 irinotecan sucrosofate 2 dehydroftorafur 2 Surgical Procedures, Operative 2 Radiosurgery 2 Pancreaticoduodenectomy 2 Chemotherapy, Adjuvant 2 Cetuximab 2 trametinib 1 tipifarnib 1 saracatinib 1 pegfilgrastim 1 lanreotide 1 ganitumab 1 durvalumab 1 conatumumab 1 beta-D-glucosylisophosphoramide mustard 1 Watchful Waiting 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Pancreatic Neoplasms × durvalumab × Clear all

NCT06094140 2026-05-06

NEO-IMPACT

Australasian Gastro-Intestinal Trials Group

Phase 2 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡